NEXT Life Sciences’ Plan A provides men with a long-acting, reversible, non-hormonal contraceptive via Vasalgel hydrogel.

A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive ...

Until now, men had very limited options when it came to contraceptive measures - like condoms or sterilization. But soon, a revolutionary option is going to be added to this list. Scientists are ...

YCT-529 inhibits retinoic acid receptor alpha to suppress sperm production reversibly. Currently in Phase 1b/2a trials, the compound has shown promise in preclinical models and aims to expand ...